Meyers Deborah A
Center for Human Genomics, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
Immunol Allergy Clin North Am. 2005 Nov;25(4):743-55. doi: 10.1016/j.iac.2005.09.002.
Several key conditions that are necessary to identify disease susceptibility genes in common diseases such as asthma are now available, including (1) increasingly comprehensive genomic information on gene location, genomic structure, and sequence variants, from the Human Genome Project (and from other species); (2) better understanding of the biologic functions of relevant genes and inflammatory and immunity pathways important in asthma; (3) newer high throughput and accurate technologies for DNA sequencing and SNP genotyping; (4) improved statistical methods for analyzing genetic data from families and populations; and (5) availability of methods to characterize function of sequence variants and study biologic responses. Collectively, these conditions will allow the prioritization of candidate genes based on available knowledge of map position and biologic relevance; obtain genomic structure of these genes; and study sequence variants in these genes in populations to facilitate the identification of genes that are important in the development and expression (severity) of asthma and associated phenotypes. Although, it is still a labor-intensive and expensive project to identify susceptibility genes in common diseases such as asthma, the new techniques that are now being used will greatly facilitate gene mapping. The techniques discussed in this article include genome-by-genome analysis in family data, such as those listed in Box 2. This analysis has already been shown to be a powerful too in mapping genes for another common disease (prostate cancer) with interesting preliminary results for asthma. Second, the use of man-mouse homology mapping that has proven very useful in cardiovascular studies is beginning to be applied to asthma and related phenotypes. finally with new available technology, genome-wide screens using very dense SNP maps are now a reality and a significant new development in family linkage and case-control association studies. In summary, these new approaches should be considered in designing studies to detect genes that are important in asthma and allergy.
现在已有几个识别常见疾病(如哮喘)易感性基因所需的关键条件,包括:(1)来自人类基因组计划(以及其他物种)的关于基因位置、基因组结构和序列变异的日益全面的基因组信息;(2)对相关基因的生物学功能以及哮喘中重要的炎症和免疫途径有了更好的理解;(3)用于DNA测序和SNP基因分型的更新的高通量且准确的技术;(4)用于分析来自家系和人群的遗传数据的改进的统计方法;以及(5)用于表征序列变异功能和研究生物学反应的方法。总体而言,这些条件将使基于图谱位置和生物学相关性的现有知识对候选基因进行优先级排序成为可能;获得这些基因的基因组结构;并研究这些基因在人群中的序列变异,以促进识别在哮喘及其相关表型的发生和表达(严重程度)中起重要作用的基因。尽管识别哮喘等常见疾病的易感性基因仍然是一个劳动密集型且昂贵的项目,但目前正在使用的新技术将极大地促进基因定位。本文讨论的技术包括对家系数据进行逐个基因组分析,如方框2中所列。这种分析已被证明是定位另一种常见疾病(前列腺癌)基因的有力工具,对哮喘也有有趣的初步结果。其次,在心血管研究中已证明非常有用的人鼠同源性图谱绘制方法开始应用于哮喘及相关表型研究。最后,随着新技术的出现,使用非常密集的SNP图谱进行全基因组筛查现在已成为现实,并且是家系连锁和病例对照关联研究中的一项重大新进展。总之,在设计检测哮喘和过敏中重要基因的研究时应考虑这些新方法。